Financial giants have made a conspicuous bearish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 11 unusual trades.
Delving into the details, we found 9% of traders were bullish, while 90% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $454,486, and 5 were calls, valued at $292,034.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $195.0 and $210.0 for AbbVie, spanning the last three months.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for AbbVie options trades today is 559.88 with a total volume of 4,547.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for AbbVie's big money trades within a strike price range of $195.0 to $210.0 over the last 30 days.
AbbVie Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | SWEEP | BEARISH | 11/15/24 | $1.88 | $1.89 | $1.89 | $207.50 | $163.1K | 223868 | |
| ABBV | PUT | SWEEP | BEARISH | 11/22/24 | $2.11 | $1.78 | $2.11 | $197.50 | $162.2K | 1781 | |
| ABBV | PUT | SWEEP | BEARISH | 11/22/24 | $2.25 | $1.91 | $2.25 | $200.00 | $78.7K | 269245 | |
| ABBV | PUT | SWEEP | BEARISH | 05/16/25 | $11.4 | $11.25 | $11.4 | $200.00 | $67.2K | 5360 | |
| ABBV | PUT | SWEEP | BEARISH | 11/22/24 | $1.66 | $1.59 | $1.66 | $197.50 | $52.2K | 11.3K |
About AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
In light of the recent options history for AbbVie, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is AbbVie Standing Right Now?
- With a trading volume of 2,248,728, the price of ABBV is up by 0.19%, reaching $202.07.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 86 days from now.
Expert Opinions on AbbVie
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $217.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* An analyst from Morgan Stanley has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $231. * An analyst from Citigroup persists with their Buy rating on AbbVie, maintaining a target price of $226. * Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on AbbVie with a target price of $215. * An analyst from BMO Capital has decided to maintain their Outperform rating on AbbVie, which currently sits at a price target of $220. * An analyst from UBS persists with their Neutral rating on AbbVie, maintaining a target price of $195.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with Benzinga Pro for real-time alerts.
